Overview
The Chemours Company, based in the United States, operates primarily in the chemicals industry. Founded as a spin-off from DuPont in 2015, Chemours specializes in the production of high-performance chemicals used in various sectors including refrigeration, electronics, and industrial processes. Among its leading products are prominent brands like Teflon and Ti-Pure. The company is also actively involved in sustainability projects; for instance, its Opteon range of refrigerants is designed to reduce environmental impact with low global warming potential. This initiative aligns with its broader commitment to Responsible Care®, emphasizing safety and environmental stewardship across its global operations. As such, Chemours represents a key player in the innovative and sustainability-driven chemical sector.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for The Chemours Company as of June 30, 2025 is 5,850.00 MM.
- The operating income for The Chemours Company as of June 30, 2025 is 351.00 MM.
- The net income for The Chemours Company as of June 30, 2025 is -412.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 5,850.00 | 351.00 | -412.00 |
| 2025-03-31 | 5,788.00 | 408.00 | 28.00 |
| 2024-12-31 | 5,782.00 | 440.00 | 86.00 |
| 2024-09-30 | 5,828.00 | 493.00 | 68.00 |
| 2024-06-30 | 5,814.00 | 508.00 | 106.00 |
| 2024-03-31 | 5,904.00 | 574.00 | -329.00 |
| 2023-12-31 | 6,078.00 | 672.00 | -238.00 |
| 2023-09-30 | 6,004.00 | 574.00 | -317.00 |
| 2023-06-30 | 6,294.00 | 671.00 | -87.00 |
| 2023-03-31 | 6,566.00 | 695.00 | 489.00 |
| 2022-12-31 | 6,831.00 | 793.00 | 578.00 |
| 2022-09-30 | 7,031.00 | 1,001.00 | 908.00 |
| 2022-06-30 | 6,933.00 | 1,020.00 | 881.00 |
| 2022-03-31 | 6,673.00 | 896.00 | 746.00 |
| 2021-12-31 | 6,345.00 | 691.00 | 608.00 |
| 2021-09-30 | 6,108.00 | 614.00 | 394.00 |
| 2021-06-30 | 5,662.00 | 458.00 | 256.00 |
| 2021-03-31 | 5,100.00 | 433.00 | 215.00 |
| 2020-12-31 | 4,969.00 | 447.00 | 219.00 |
| 2020-09-30 | 4,984.00 | 355.00 | -117.00 |
Income Statement: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | 0.19 | 0.18 |
| 2024-12-31 | 0.58 | 0.57 |
| 2024-09-30 | 0.53 | 0.51 |
| 2024-06-30 | 0.79 | 0.78 |
| 2024-03-31 | -2.21 | -2.21 |
| 2023-12-31 | -1.60 | -1.60 |
| 2023-09-30 | -2.12 | -2.12 |
| 2023-06-30 | -0.58 | -0.58 |
| 2023-03-31 | 3.20 | 3.15 |
| 2022-12-31 | 3.72 | 3.65 |
| 2022-09-30 | 5.73 | 5.61 |
| 2022-06-30 | 5.47 | 5.35 |
| 2022-03-31 | 4.56 | 4.45 |
| 2021-12-31 | 3.69 | 3.60 |
| 2021-09-30 | 2.38 | 2.33 |
| 2021-06-30 | 1.55 | 1.52 |
| 2021-03-31 | 1.30 | 1.29 |
| 2020-12-31 | 1.33 | 1.32 |
| 2020-09-30 | -0.71 | -0.72 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for The Chemours Company as of June 30, 2025 is 258.00 MM.
- The cash from investing activities for The Chemours Company as of June 30, 2025 is -310.00 MM.
- The cash from financing activities for The Chemours Company as of June 30, 2025 is -26.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | 258.00 | -310.00 | -26.00 |
| 2025-03-31 | -455.00 | -338.00 | -39.00 |
| 2024-12-31 | -633.00 | -353.00 | -36.00 |
| 2024-09-30 | -289.00 | -376.00 | -126.00 |
| 2024-06-30 | -297.00 | -243.00 | 225.00 |
| 2024-03-31 | 390.00 | -233.00 | 186.00 |
| 2023-12-31 | 556.00 | -229.00 | 172.00 |
| 2023-09-30 | 235.00 | -164.00 | -14.00 |
| 2023-06-30 | 405.00 | -296.00 | -513.00 |
| 2023-03-31 | 629.00 | -271.00 | -565.00 |
| 2022-12-31 | 755.00 | -284.00 | -686.00 |
| 2022-09-30 | 808.00 | 203.00 | -696.00 |
| 2022-06-30 | 818.00 | 209.00 | -762.00 |
| 2022-03-31 | 783.00 | 187.00 | -707.00 |
| 2021-12-31 | 814.00 | 220.00 | -554.00 |
| 2021-09-30 | 959.00 | -236.00 | -546.00 |
| 2021-06-30 | 947.00 | -205.00 | -659.00 |
| 2021-03-31 | 802.00 | -199.00 | -336.00 |
| 2020-12-31 | 807.00 | -234.00 | -449.00 |
| 2020-09-30 | 854.00 | -296.00 | -321.00 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for The Chemours Company as of June 30, 2025 is 61.14.
- The p/book for The Chemours Company as of June 30, 2025 is 2.95.
- The p/tbv for The Chemours Company as of June 30, 2025 is 3.22.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | 61.14 | 2.95 | 3.22 |
| 2025-03-31 | 23.84 | 3.39 | 3.69 |
| 2024-12-31 | 3.81 | 4.12 | |
| 2024-09-30 | 27.13 | 4.27 | 4.99 |
| 2024-06-30 | -10.39 | 4.56 | 5.30 |
| 2024-03-31 | 5.80 | 6.76 | |
| 2023-12-31 | -15.15 | 6.18 | 7.20 |
| 2023-09-30 | -47.78 | 5.13 | 5.94 |
| 2023-06-30 | 10.95 | 4.36 | 4.80 |
| 2023-03-31 | 7.71 | 4.02 | |
| 2022-12-31 | 3.60 | 3.96 | |
| 2022-09-30 | 3.15 | 3.48 | |
| 2022-06-30 | 4.27 | 4.70 | |
| 2022-03-31 | 8.25 | 4.63 | 5.15 |
| 2021-12-31 | 13.88 | 5.47 | 6.15 |
| 2021-09-30 | 18.75 | 5.33 | 6.50 |
| 2021-06-30 | |||
| 2021-03-31 | 25.96 | 6.55 | 8.10 |
| 2020-12-31 | 25.40 | 6.83 | 8.58 |
| 2020-09-30 | -47.41 | 7.56 | 9.82 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for The Chemours Company as of June 30, 2025 is 0.01.
- The ebit (3y)/ev for The Chemours Company as of June 30, 2025 is 0.01.
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | 0.01 | 0.01 |
| 2025-03-31 | 0.02 | 0.02 |
| 2024-12-31 | 0.01 | 0.03 |
| 2024-09-30 | 0.01 | 0.05 |
| 2024-06-30 | -0.06 | 0.05 |
| 2024-03-31 | -0.04 | 0.05 |
| 2023-12-31 | -0.04 | 0.05 |
| 2023-09-30 | -0.00 | 0.06 |
| 2023-06-30 | 0.08 | 0.08 |
| 2023-03-31 | 0.11 | 0.09 |
| 2022-12-31 | 0.16 | 0.06 |
| 2022-09-30 | 0.17 | 0.06 |
| 2022-06-30 | 0.11 | 0.04 |
| 2022-03-31 | 0.09 | 0.03 |
| 2021-12-31 | 0.05 | 0.02 |
| 2021-09-30 | 0.03 | 0.02 |
| 2021-06-30 | ||
| 2021-03-31 | 0.02 | 0.04 |
| 2020-12-31 | 0.02 | 0.05 |
| 2020-09-30 | -0.03 | 0.06 |
Management Effectiveness
- The roa for The Chemours Company as of June 30, 2025 is 0.00.
- The roe for The Chemours Company as of June 30, 2025 is 0.04.
- The roic for The Chemours Company as of June 30, 2025 is 0.01.
- The croic for The Chemours Company as of June 30, 2025 is -0.17.
- The ocroic for The Chemours Company as of June 30, 2025 is -0.09.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-06-30 | 0.00 | 0.04 | 0.01 | -0.17 | -0.09 |
| 2025-03-31 | 0.01 | 0.11 | 0.02 | -0.21 | -0.13 |
| 2024-12-31 | 0.01 | 0.10 | 0.02 | -0.16 | -0.06 |
| 2024-09-30 | 0.01 | 0.15 | 0.02 | -0.07 | -0.06 |
| 2024-06-30 | -0.04 | -0.27 | -0.07 | 0.07 | 0.08 |
| 2024-03-31 | -0.03 | -0.21 | -0.05 | 0.10 | 0.11 |
| 2023-12-31 | -0.04 | -0.24 | -0.06 | 0.02 | 0.05 |
| 2023-09-30 | -0.01 | -0.07 | -0.02 | -0.09 | 0.09 |
| 2023-06-30 | 0.06 | 0.40 | -0.02 | -0.09 | 0.09 |
| 2023-03-31 | 0.08 | 0.50 | 0.10 | -0.04 | 0.12 |
| 2022-12-31 | 0.12 | 0.91 | 0.18 | 0.05 | 0.16 |
| 2022-09-30 | 0.12 | 0.88 | 0.17 | 0.05 | 0.16 |
| 2022-06-30 | 0.10 | 0.83 | 0.17 | 0.04 | 0.16 |
| 2022-03-31 | 0.08 | 0.71 | 0.14 | 0.05 | 0.15 |
| 2021-12-31 | 0.06 | 0.48 | 0.12 | 0.09 | 0.19 |
| 2021-09-30 | 0.04 | 0.35 | 0.08 | 0.03 | 0.18 |
| 2021-06-30 | 0.04 | 0.39 | 0.05 | 0.02 | 0.19 |
| 2021-03-31 | 0.03 | 0.33 | 0.04 | 0.06 | 0.16 |
| 2020-12-31 | 0.03 | 0.32 | 0.04 | 0.03 | 0.16 |
| 2020-09-30 | -0.02 | -0.14 | -0.02 | 0.05 | 0.17 |
Gross Margins
- The gross margin for The Chemours Company as of June 30, 2025 is 0.19.
- The net margin for The Chemours Company as of June 30, 2025 is 0.00.
- The operating margin for The Chemours Company as of June 30, 2025 is 0.07.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-06-30 | 0.19 | 0.00 | 0.07 |
| 2025-03-31 | 0.20 | 0.01 | 0.08 |
| 2024-12-31 | 0.20 | 0.01 | 0.20 |
| 2024-09-30 | 0.20 | 0.02 | 0.19 |
| 2024-06-30 | 0.21 | -0.06 | 0.10 |
| 2024-03-31 | 0.22 | -0.04 | -0.01 |
| 2023-12-31 | 0.21 | -0.05 | -0.02 |
| 2023-09-30 | 0.22 | -0.01 | 0.11 |
| 2023-06-30 | 0.23 | -0.01 | 0.01 |
| 2023-03-31 | 0.24 | 0.07 | 0.11 |
| 2022-12-31 | 0.26 | 0.13 | 0.15 |
| 2022-09-30 | 0.26 | 0.13 | 0.14 |
| 2022-06-30 | 0.24 | 0.13 | 0.15 |
| 2022-03-31 | 0.22 | 0.11 | 0.13 |
| 2021-12-31 | 0.21 | 0.10 | 0.11 |
| 2021-09-30 | 0.20 | 0.06 | 0.10 |
| 2021-06-30 | 0.20 | 0.05 | 0.08 |
| 2021-03-31 | 0.21 | 0.04 | 0.09 |
| 2020-12-31 | 0.04 | 0.09 | |
| 2020-09-30 | 0.18 | -0.02 | 0.07 |
Identifiers and Descriptors
| Central Index Key (CIK) | 1627223 |
Industry Groups
| SIC 28 - Chemicals And Allied Products |
